Health care economics Archives - Page 27 of 27 - Inside Precision Medicine

Inside Precision Medicine Elements of Change—How Molecular Diagnostics and Histology Will Deliver Growth to U.S. IVD Market

Elements of Change—How Molecular Diagnostics and Histology Will Deliver Growth to U.S. IVD Market

Molecular Dx

Elements of Change—How Molecular Diagnostics and Histology Will Deliver Growth to U.S. IVD Market

Emil Salazar

August 13, 2014

Source: © Igor Mojzes - Fotolia.com

News & Features

Personalized Medicine Proponents Focus on Patients, Insurers

Alex Philippidis

July 23, 2014

Greg Lucier has made his first investment since his days as chairman and CEO of Life Technologies as a member of the investor group behind Edico Genome.

News & Features

Edico Genome Draws Greg Lucier among Investors

Alex Philippidis

July 17, 2014

Will Liability Drive Personalized Medicine?

Molecular Dx

Will Liability Drive Personalized Medicine?

Gary E. Marchant and Rachel A. Lindor

July 16, 2014

MDx is a growing market

Molecular Dx

Top 14 Molecular Diagnostics Firms

June 2, 2014

Clinical OMICs Magazine: Volume 3

News & Features

Labs Face Medicare Cuts, New Codes

Alex Philippidis

May 29, 2014

1...25 2627Page 27 of 27

Related Content

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

Tongue Cancer Organoids Reveal Key Pathways for Overcoming Drug Resistance

Tongue Cancer Organoids Reveal Key Pathways for Overcoming Drug Resistance

Mayo Clinic, Ambry Genetics Functionally Map 99% of all BRCA2 Hotspot SNVs

Mayo Clinic, Ambry Genetics Functionally Map 99% of all BRCA2 Hotspot SNVs

Treating All the Not-So-Rare “Rare Disease” Patients at Major Care Centers

Treating All the Not-So-Rare “Rare Disease” Patients at Major Care Centers